Dr Shahid Yousuf

Dr. Dr Shahid Yousuf

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2024 in Toxicon
Verified
Journal Article
Closed access
WSWajid Mohammad Sheikh
Wajid Mohammad Sheikh
IJIndrani Jadhav
Indrani Jadhav
MSMajid Shafi
Majid Shafi
SBShowkeen Muzamil Bashir
Showkeen Muzamil Bashir
JJJasmeena Jan
Jasmeena Jan
DYDr Shahid Yousuf
Dr Shahid Yousuf

11 February 2026 in Brain Sciences
Verified
Journal Article
Open access
PDF file
SRShahzada Rashid
Shahzada Rashid
William James AntonisamyWilliam James Antonisamy
William James Antonisamy
Faheem ShehjarFaheem Shehjar
Faheem Shehjar
DYDr Shahid Yousuf
Dr Shahid Yousuf
Zahoor A. ShahZahoor A. Shah
Zahoor A. Shah
Background: Engagement of the NF-κB signaling pathway is crucial for controlling immune and inflammatory gene expression within the central nervous system (CNS). Naringenin, a flavonoid derived from citrus fruits, is known for its anti-inflammatory and antioxidant effects; however, its impact on LPS-induced neuroinflammation in HMC3 (human microglial) and SH-SY5Y (neuronal) cell lines has not been thoroughly studied. Objectives: We sought to ascertain the neuroprotective role of Naringenin in LPS-induced neuroinflammation in microglia and neuronal cell lines with a focus on modulation of the NF-κB signaling pathway. Methods: LPS treatment was given to HMC3 cells to induce an inflammatory response, besides the secretome of HMC3 cells was transfered to SH-SY5Y cells with the administration of Naringenin. A cell viability assay, ROS level measurements, Western blotting, and immunocytochemistry were employed to quantify and localize NF-κB and pro-inflammatory cytokines (TNF-α, IL-6, IL-1β). Nuclear fractions of NF-κB were analyzed to screen its activation and translocation. Results: Naringenin treatment led to a dose-dependent decrease in LPS-induced reactive oxygen species (ROS) production. It significantly reduced the expression of pro-inflammatory cytokines and inhibited NF-κB activation in HMC3 cells. The nuclear translocation of NF-κB was notably diminished after treatment, as demonstrated by both Western blot and immunocytochemistry. These results suggest that Naringenin exerts an anti-inflammatory effect by suppressing the NF-κB signaling pathway. Conclusions: The findings suggest the potential therapeutic role of Naringenin using in vitro models in mitigating neuroinflammation through modulation of the NF-κB signaling pathway.

14 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
SRShahzada Rashid
Shahzada Rashid
William James AntonisamyWilliam James Antonisamy
William James Antonisamy
Faheem ShehjarFaheem Shehjar
Faheem Shehjar
DYDr Shahid Yousuf
Dr Shahid Yousuf
Zahoor A. ShahZahoor A. Shah
Zahoor A. Shah
Background: Engagement of the NF-κB signaling pathway is crucial for controlling im-mune and inflammatory gene expression within the central nervous system (CNS). Naringenin, a flavonoid derived from citrus fruits, is known for its anti-inflammatory and antioxidant effects; however, its impact on LPS-induced neuroinflammation in HMC3 (human microglial) and SH-SY5Y (neuronal) cell lines has not been thoroughly studied. Objectives: To ascertain the neuroprotective role of Naringenin on LPS-induced neuroin-flammation in microglia and neuronal cell lines with focus on modulation of NF-κB sig-naling pathway. Methods: LPS treatment was given to HMC3 cells to induce an inflam-matory response and secretome of HMC3 cells to SH-SY5Y cells with the administration of Naringenin. The cell viability assay, ROS levels, Western blotting, immunocytochemis-try were employed to quantify and localize NF-κB and pro-inflammatory cytokines (TNF-α, IL-6, IL-1β). Nuclear and cytosolic fractions of NF-κB were analyzed to screen its activation and translocation. Results: Naringenin treatment led to a dose-dependent de-crease in LPS-induced reactive oxygen species (ROS) production. It significantly reduced the expression of pro-inflammatory cytokines and inhibited NF-κB activation in HMC3 cells. The nuclear translocation of NF-κB was notably diminished after treatment, as demonstrated by both western blot and immunocytochemistry. These results suggest that Naringenin exerts an anti-inflammatory effect by suppressing the NF-κB signaling path-way. Conclusion: The findings suggest the potential therapeutic role of Naringenin using in vitro models in mitigating neuroinflammation through modulation of NF-κB signaling pathway.